Recombinant Human Lactoferrin to Reduce Immune Activatio

Project: Research project

Project Details

Description

Recombinant Human Lactoferrin to Reduce Immune Activation and Coagulation Among HIV Positive Patients
StatusFinished
Effective start/end date9/1/148/31/15

Funding

  • Hennepin Healthcare Research Institute

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.